Global blood collection devices market accounted for USD 9.52 billion in 2021 and is projected to reach USD 14.22 billion by 2028, registering over 5.9% CAGR during the review timeframe.

Industry Snapshot:
 

• The rising incidence of infectious diseases is one of the main factors propelling the growth of the overall market during the forecast period.
• The increasing number of product developments is estimated to drive expansion in the business sphere.
• The growing number of accidents and trauma cases is contributing to global blood collection devices market development.
• The unavailability of skilled professionals will stymie industry expansion between 2022 and 2028.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5490027/

Segmental Overview:

Product Type	Blood Collection Sets
	Blood Collection Needles/ Holders
	Collection Tubes
	Others
Method	Automated Blood Collection
	Manual Blood Collection
End-user Terrain	Blood Banks
	Hospitals and Pathology Laboratories
	Others
Regional Outlook	North America
	Asia Pacific
	Europe
	Latin America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predictions Corner:
 

• North America market is expected to capture a substantial revenue share in the forthcoming years, due to the growing prevalence of chronic diseases, high R&D spending on healthcare activities, and availability of government funding to develop new blood-related equipment.
• Asia Pacific global blood collection devices market is estimated to register a healthy CAGR during 2022-2028, owing to the availability of favorable government policies, growing R&D activities, and increasing number of startups and biotech companies.

Explainer – All you need to know

For those unaware, blood collection devices are medical devices that interact with blood to change its composition, plasma, or serum fractions. A more common substance that can alter blood constituent stability and analytical systems is blood-dissolving tube additives. 

These development in blood collection devices by prominent market players, the growing blood donation campaigns, and the development of liquid biopsy technology that uses blood collection devices to provide ease-of-use in the diagnostic process and better accuracy and precision are some of the additional factors catalyzing the overall market growth.

FL MEDICAL s.r.l., Narang Medical Limited, Sekisui Chemical Co. Ltd., Grenier Inc., Thermo Fisher Scientific Inc., Nipro Corporation, Sarstedt AG and Co. KG., Cardinal Health Inc., Terumo Corporation, and Becton, Dickinson and Company are the leading companies operating in global blood collection devices industry.

Concluding lines:

Market researchers collect, present, and analyze data to accurately represent the various aspects of a commercial landscape. MarketStudyReport has a report titled ‘Global Blood Collection Devices Market Size study, By Product (Blood Collection Tubes, Blood Collection Needles/ Holders, Blood Collection Sets, Others), By Method (Manual Blood Collection, Automated Blood Collection), By End User (Hospitals and Pathology Laboratories, Blood Banks, Others), and Regional Forecasts 2022-2028’, which diligently examines the shifting market patterns, potential business prospects, and challenges present in this business vertical.